Effect of Talampanel (an AMPA Receptor Blocker) on Brain Activity
Clinical trial NCT00057460 · COMPLETED
Trial details
- NCT number
- NCT00057460
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.